Mesoblast (MESO) Receivables (2015 - 2025)

Mesoblast (MESO) has reported Receivables for 11 consecutive years, with $43.3 million the latest figure, recorded in Q4 2025.

• Quarterly Receivables rose 106.66% year-over-year to $43.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.3 million (up 106.66% YoY) and the FY2025 annual result came in at $14.9 million, down 29.05% from the prior year.
• Receivables grew to $43.3 million in Q4 2025 per MESO's latest filing, from $14.9 million in the prior quarter.
• Over the last five years, Receivables for MESO reached as high as $43.3 million in Q4 2025 and fell as low as $2.9 million in Q1 2021.
• A 5-year average of $10.4 million and a median of $5.6 million in 2022 frame the typical range for Receivables.
• Annual changes were most pronounced in 2021 — Receivables jumped 207.62% — and 2022, when it slumped 31.35%.
• Year by year, Receivables stood at $6.0 million in 2021, then decreased by 27.2% to $4.4 million in 2022, then soared by 58.94% to $7.0 million in 2023, then surged by 199.4% to $21.0 million in 2024, then jumped by 106.66% to $43.3 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $43.3 million, $14.9 million, and $21.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.